Showing posts with label
Base editing
.
Show all posts
Showing posts with label
Base editing
.
Show all posts
Monday, January 12, 2026
Why we own BEAM Therapeutics - update January 2026
›
Beam Therapeutics (NASDAQ: BEAM) Updated Investment & Business Report – January 2026 Theme: Precision genetic medicine through base...
Friday, December 12, 2025
BEAM Therapeutics continues on it's path to change medicine with Base editing of DNA
›
Beam Therapeutics (NASDAQ: BEAM) — Updated Business/Investment Report As of: December 12, 2025 (America) Core proposition: Beam is dev...
Thursday, November 6, 2025
Beam Therapeutics has moved from promise to proof: Update/Mini Report
›
Here is an update and mini-report on Beam Therapeutics (NASDAQ: BEAM) that summarizes its base-editing breakthroughs, financials, and i...
Friday, June 20, 2025
We've been collecting these smallcap biotech and healthcare stocks this year! Here's why!
›
Small-Cap Biotech & Healthcare Stocks Poised for Growth 📈 Sector Outlook: Why Biotech + AI = Exponential Growth Biotech is entering...
›
Home
View web version
